TERT promoter mutations in melanoma survival

Despite advances in targeted therapies, the treatment of advanced melanoma remains an exercise in disease management, hence a need for biomarkers for identification of at risk primary melanoma patients. In this study we aimed to assess the prognostic value of TERT promoter mutations in primary melan...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Cancer
Autori principali: Nagore, Eduardo, Heidenreich, Barbara, Rachakonda, Sívaramakrishna, Garcia-Casado, Zaida, Requena, Celia, Soriano, Virtudes, Frank, Christoph, Traves, Victor, Quecedo, Esther, Sanjuan-Gimenez, Josefa, Hemminki, Kari, Teresa Landi, Maria, Kumar, Rajiv
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238633/
https://ncbi.nlm.nih.gov/pubmed/26875008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30042
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi